Skip to main content
Caplight Logo









Ember LifeSciences

Ember LifeSciences

Private
Westlake Village, CaliforniaHealthcare & Life Scienceshttps://www.emberlifesciences.com/

Last Round

Series A

May 27, 2026

Total Funding Raised

$54M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Ember LifeSciences is a cold chain technology company that provides self-refrigerated, cloud-based shipping solutions for the transport of temperature-sensitive pharmaceuticals and vaccines.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Logistics Software, Supply Chain Tracking, Circular Economy, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Data as a Service

AI Layer

Non-AI

Keywords

cold chaintemperature-controlled shippingpharma logisticsIoT shippingreusable packagingcold chain monitoringbiotech supply chainlogistics softwarereal-time trackingcircular logisticsSaaSsmart shippingcold chain techpharma supply chainlogistics as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ember LifeSciences Comparables

Compare Ember LifeSciences with similar companies based on industry and business-model similarity.

Ember LifeSciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Artyc
89%
SkyCell
79%
Cold Chain Technologies
76%

Ember LifeSciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 27, 2026
Early Stage VCMar 3, 2026
Series ADec 16, 2025
Early FundingFeb 14, 2023

Ember LifeSciences Investors

Notable investors and investment history

Ember LifeSciences investors
InvestorRounds
TDF VenturesSeries A
Carrier VenturesSeries A, Early Funding
Amgen VenturesSeries A
Sea Court CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2026

    Open roles increased to 8, 3.1x the trailing average.

  • Aug 10, 2026

    Open roles increased to 5, 19% of headcount.

Ember LifeSciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ember LifeSciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ember LifeSciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersWestlake Village, California
Employee Range27
Year Founded2022
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?